Showing 1090 – 1100 of 1307 results
-
Initiation
William Blair initiated research coverage of CSG Systems International, Inc. (CSGS $55.18), a revenue and customer management, customer engagement, and monetization solution provider that enables clients to monetize relationships with the end-customer.
-
HashiCorp Inc Initiation
William Blair initiated research coverage of HashiCorp, Inc. (HCP $90.54), which provides infrastructure automation software solutions to enterprises around the world.
-
UserTesting Inc Initiation
William Blair initiated research coverage of UserTesting, Inc. (USER $8.13), which provides customers with a leading software platform for human insights and video-first user feedback.
-
Braze Inc Initiation
William Blair initiated research coverage of Braze, Inc. (BRZE $66.95). Braze is a leading customer engagement platform that deploys a streaming data architecture to orchestrate, personalize, and deliver marketing campaigns to customers.
-
Bionomics Limited Initiation
William Blair initiated research coverage of Bionomics Limited (BNOX $11.52), a clinical-stage biopharma company based in Australia with U.S. operations developing small-molecule ion channel modulators to treat central nervous system disorders.
-
Nkarta Inc Initiation
William Blair initiated research coverage of Nkarta, Inc. (NKTX $14.27), a clinical-stage company focused on the development and commercialization of genetically engineered allogeneic chimeric antigen receptor (CAR) natural killer (NK) cell therapies for the treatment of cancer.
-
Cyxtera Technologies Inc Initiation
William Blair initiated research coverage of Cyxtera Technologies, Inc. (CYXT $11.56), a global carrier-neutral data center operator focused on retail colocation and interconnection services.
-
Alnylam Pharmaceuticals Inc Initiation
William Blair initiated research coverage of Alnylam Pharmaceuticals, Inc. (ALNY $131.52), the premier commercial-stage siRNA therapeutics company. Alnylam has four approved therapies and over eight additional candidates in clinical development.
-
Arcellx Inc Initiation of Research Coverage
William Blair initiated research coverage of Arcellx, Inc. (ACLX $16.97), a clinical-stage company focused on the development and commercialization of first-in-class adaptive immune cell therapies that can be readily activated and reprogrammed.
-
Sierra Wireless Inc Initiation
William Blair initiated research coverage of Sierra Wireless, Inc. (SWIR $16.45), a preferred IoT solutions provider that combines edge devices (e.g., cellular routers/gateways and modules), connectivity services, software, security, and a secure cloud platform to simplify IoT deployments.